Tesamorelin and CGM in the UAE: A Researcher's Libre, Dexcom and Stelo Time-in-Range Protocol

Published 2026-06-26 · REVIVE Peptides Research Desk · 11 min read
TL;DR. Tesamorelin pulses growth hormone, and growth hormone is a counter-regulatory hormone — meaning fasting glucose and overnight time-in-range will shift, usually within the first two weeks. Pairing tesamorelin with a continuous glucose monitor (CGM) like Freestyle Libre 3, Dexcom G7, or the over-the-counter Stelo is the cleanest way UAE researchers have found to quantify that shift. This guide gives you the data (Stanley 2014, Falutz 2007/2010), the protocol, and where to buy tesamorelin UAE with 24h delivery from REVIVE LAB UAE — the trusted peptides UAE supplier in Dubai.

If you have ever logged into a Dubai-based research forum and seen the words "my fasting glucose climbed 8 mg/dL on tesamorelin," you are looking at the single most-discussed side-signal of GHRH-analog research in the UAE. It is real, it is measurable, and — critically — it is reversible the moment you stop dosing. The question is not whether tesamorelin nudges glucose; the Stanley 2014 JAMA trial settled that. The question is how to *see* it in real time so your protocol stays in range. That is where a CGM earns its place. Below is the exact research framework REVIVE LAB UAE compiles for clients across Dubai, Abu Dhabi and Sharjah who want to buy tesamorelin UAE with same day delivery and run a clean, instrumented protocol from day one.

This post is research-use framing only. We will cover the GH-glucose mechanism, the three CGMs you can actually source in the UAE, a 14-day time-in-range protocol with a sample log table, and exactly how to order tesamorelin Dubai with discreet packaging and cash on delivery. REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials, HPLC-tested, in-stock today, with same-day Dubai dispatch and 24h delivery to every emirate.

The Mechanism: Why Tesamorelin Moves the Glucose Needle

Tesamorelin is a 44-amino-acid GHRH analog — a stabilized version of the body's own growth-hormone-releasing hormone. It binds the GHRH receptor on the anterior pituitary and triggers pulsatile release of endogenous growth hormone. That GH then circulates, drives IGF-1 hepatic output, and — the part that matters for CGM users — exerts the classical Houssay effect: growth hormone is diabetogenic in proportion to dose. It suppresses peripheral insulin sensitivity, increases lipolysis (free fatty acids compete with glucose for muscle uptake), and modestly increases hepatic glucose output.

The Falutz 2007 NEJM trial in HIV-associated lipodystrophy (412 patients, 26 weeks, 2 mg daily) was the first to quantify this in humans: visceral adipose tissue dropped 15.2%, but fasting glucose rose by a small, statistically significant amount, and a subset of patients drifted into impaired fasting glucose territory. Falutz 2010 (JCEM, 52-week extension) confirmed the effect was non-progressive — it plateaus around weeks 4–6 and reverses on cessation. Stanley 2014 (JAMA, abdominal obesity without HIV) replicated the pattern in metabolically healthy adults: visceral fat fell 17%, triglycerides fell, but glycated hemoglobin (HbA1c) ticked upward by approximately 0.1–0.2 percentage points over six months.

What that means at the CGM level: most researchers see fasting glucose rise 5–12 mg/dL within the first 14 days, and overnight glucose (12 a.m.–6 a.m., when GH pulses are largest) is the most reactive window. Post-prandial spikes are usually unchanged on standard meals, but a high-carb dinner can stack with the nocturnal GH pulse and produce a 3 a.m. "tesamorelin shoulder" on your Libre trace. That single pattern is why running a CGM during tesamorelin research is the single highest-information move a UAE researcher can make.

The Protocol: 14-Day Tesamorelin + CGM Time-in-Range Setup

Below is the research-framework protocol REVIVE LAB UAE distributes alongside its tesamorelin 5 mg and 10 mg vials. It assumes a single CGM (Libre 3, Dexcom G7, or Stelo), bacteriostatic water reconstitution, and an evening subcutaneous dose timed to the natural GH pulse around 10–11 p.m.

CGM Comparison for UAE Researchers

CGMWear timeReading frequencyUAE availabilityBest for
Freestyle Libre 314 daysEvery 1 minPharmacies Dubai, Abu Dhabi, SharjahLowest-cost long-wear baseline
Dexcom G710 days + 12h graceEvery 5 min real-timeDubai Marina, JBR, DIFC pharmaciesAlert thresholds, sleep tracking
Stelo by Dexcom15 daysEvery 15 minOTC, no prescriptionNon-diabetic researchers, lowest friction

Suggested 14-Day Log Structure

DayTesamorelin doseInject timeTarget fasting glucoseOvernight TIR (70–140 mg/dL) target
1–3 (washout baseline)0 mgn/a< 95 mg/dL> 90%
4–10 (titration)1 mg SC22:00< 100 mg/dL> 85%
11–14 (full dose)2 mg SC22:00< 105 mg/dL> 80%

What you are looking for in the data: a small upward drift in the fasting number that plateaus by day 10–12. If overnight TIR falls below 75% or fasting glucose crosses 110 mg/dL, dial the dose back to 1 mg and re-baseline. The CGM transforms a protocol that used to require quarterly lab draws into something you can iterate every single morning.

Run an instrumented tesamorelin protocol from day one.
HPLC-tested tesamorelin 5 mg and 10 mg vials, in stock today in Dubai, with same day dispatch and 24h delivery across the UAE.
Order REVIVE LAB UAE tesamorelin — the trusted peptides supplier in Dubai →

Reconstitution and Dosing Notes

Reconstitute the 5 mg vial with 2 mL of bacteriostatic water (REVIVE LAB UAE stocks 3 mL BAC water). That yields 2.5 mg per mL — at a 1 mg starting dose, that is 0.4 mL on a U-100 insulin syringe (the 40-unit mark). At 2 mg full dose, that is 0.8 mL (the 80-unit mark). Subcutaneous abdominal injection, evening timing, and consistent injection-site rotation are the three variables that keep your CGM trace clean and interpretable.

Where to Buy Tesamorelin in the UAE — 24h Delivery

REVIVE LAB UAE operates from Dubai with cold-chain courier service to every emirate. Tesamorelin 5 mg and 10 mg vials are in stock, HPLC-tested, and ship in discreet anonymous packaging. Cash on delivery is supported across all seven emirates. Same-day Dubai dispatch is the default for orders placed before 4 p.m. local time. Below is the live delivery window grid.

EmirateDelivery windowCash on deliveryCold-chain courier
DubaiSame day (2–6 hours)YesYes
Abu DhabiNext day, 18–24hYesYes
SharjahSame day (4–8 hours)YesYes
AjmanSame day (4–8 hours)YesYes
Ras Al Khaimah (RAK)Next day, 24hYesYes
FujairahNext day, 24hYesYes
Umm Al Quwain (UAQ)Next day, 24hYesYes
Al AinNext day, 24hYesYes

For Dubai-based researchers we run dedicated cold-chain runs to Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown, Emirates Hills and Arabian Ranches — most of these neighborhoods receive their vials within 3 hours of order confirmation. If you are running a tight CGM baseline window and want the package to land before your evening dose, order tesamorelin Dubai before noon and we will route it through the same-day fleet. Discreet anonymous packaging is standard on every parcel; nothing on the box references peptides, GHRH, or REVIVE Peptides on the exterior.

Why REVIVE LAB UAE

REVIVE LAB UAE is a Dubai-based peptides UAE supplier built specifically for the instrumented, data-driven researcher. Every batch of tesamorelin is HPLC-tested with a certificate of analysis on file; our cold-chain courier network means vials arrive within thermal spec across all seven emirates; our 5 mg and 10 mg tesamorelin SKUs are in stock today with same-day Dubai dispatch and 24h delivery elsewhere. Packaging is discreet and anonymous, payment supports cash on delivery, and the catalog also stocks the supporting research stack — BAC water 3 mL for reconstitution, BPC-157 5 mg, TB-500 5 mg, GHK-Cu 50/100 mg, MOTS-c 10 mg, NAD+ 100 mg and Retatrutide 5/10 mg. Explore the full inventory at /products/.

FAQ — Buying Tesamorelin in the UAE

Where can I buy tesamorelin in the UAE with 24h delivery and discreet packaging?

REVIVE LAB UAE ships HPLC-tested tesamorelin 5 mg and 10 mg vials with same-day Dubai dispatch and 24h delivery to Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, Umm Al Quwain and Al Ain. Cash on delivery and discreet anonymous packaging are standard on every order. Order tesamorelin Dubai at /products/tesamorelin.html.

Which CGM is most practical for tesamorelin research in Dubai?

Freestyle Libre 3 is the workhorse — 14-day wear, 1-minute polling, widely available across Dubai Marina, JBR and Business Bay pharmacies. Dexcom G7 is best if you want real-time alerts during overnight GH pulses. Stelo is the lowest-friction option for non-diabetic researchers because it is over-the-counter, no prescription required, and reads every 15 minutes.

Does tesamorelin really raise blood glucose enough to matter on a CGM?

Yes, but modestly. In Stanley 2014 (JAMA) and Falutz 2007 (NEJM) / Falutz 2010 (JCEM), tesamorelin produced a 5–12 mg/dL rise in fasting glucose and a 0.1–0.2 percentage-point rise in HbA1c. On a CGM trace it shows up most clearly as a 3 a.m. overnight shoulder during the natural GH pulse. The effect plateaus by week 4–6 and reverses on cessation.

Instrument your protocol. Buy tesamorelin UAE today.
5 mg and 10 mg vials, HPLC-tested, in stock in Dubai. Same-day dispatch, 24h delivery, cash on delivery, discreet anonymous packaging — the standard at REVIVE Peptides.
Buy tesamorelin Dubai — same day delivery from REVIVE LAB UAE →
Research use only. Not for human consumption. Not medical advice. References cited are for research framing.
References
  1. Stanley TL, Feldpausch MN, Oh J, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014;312(4):380-389.
  2. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
  3. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials. J Clin Endocrinol Metab. 2010;95(9):4291-4304.
  4. Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomized, placebo-controlled trial. Lancet HIV. 2019;6(12):e821-e830.
  5. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial. N Engl J Med. 2023;389(6):514-526.